| --- | --- | |-----------------------------|-------| | | | | Second Quarter 2022 Results | | | July 27, 2022 | | Agenda 1 Opioid litigation updates 2 Second quarter 2022 results 3 Strategy update and 2027 long-term financial targets 4 Q&A teva Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to ...